Issue Highlights

Wed, 10/15/2014 - 23:24

The following case is the third in a series of transradial-focused reports directed by section editor Dr. Samir Pancholy. This case series is supported by an educational grant from Medtronic.

| Read More
Wed, 10/15/2014 - 23:15

A 46-year-old female presented with a non-healing wound on the right foot. Duplex ultrasound suggested an occluded distal right superficial femoral artery (SFA). Single leg right lower extremity arteriogram runoff revealed the 100% occlusion in the distal right SFA before Hunter’s canal (Figure 1), mild atherosclerotic disease in the right profunda femours, and 3-vessel runoff to the right foot.

| Read More
Wed, 10/15/2014 - 23:07

Alan Cribier, in Europe, has been doing a minimalist approach long before us, so the idea came from him. Dr. Babaliaros had trained with Dr. Cribier in 2004. We decided to try some of the things in the U.S. that Dr. Cribier is doing in France, which is basically what we call the minimalist approach (a name which doesn’t actually reflect the complexities of this type of procedure).

| Read More

NEWS

Mon, 10/20/14 - 10:07am

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native America

| Full Article
Fri, 10/17/14 - 12:44pm

October 16, 2014 — A long-term follow-up study reports on the safety and success of drug-eluting balloon angioplasty in treating patients with

| Full Article
Tue, 10/14/14 - 1:36pm

Late-Breaking ADVANCE Direct Aortic Study Presented at EACTS Reaffirms CoreValve System’s Positive Performance with Low Mortality and StrokeMINNEAPOLIS and MILAN – Oct. 13, 2014 –Medtronic, Inc. today announced positive data from nine European centers

| Full Article
Tue, 10/14/14 - 9:33am

The LPL Deficiency Association Is the First Organization Established as Part of NORDs RARELaunch Initiative

Danbury, Conn. – October 14, 2014 – The National Organization for Rare Disorders (NORD) has established the first patient organization dedicated to those living with the very rare genetic disease, lipoprotein lipase deficiency (LPLD)

| Full Article

IMAGES FROM CLD

FROM THE CURRENT ISSUEView More

Jeff Chambers, MD, Medical Director, Nancy Hintz, RN, BSN, CCRN, Cath Lab Manager, Samantha Ratka, CVT, Coon Rapids, Minnesota

Mercy Hospital has five total cath laboratories. Two rooms are dedicated to electrophysiology, one room is predominately for peripheral intervention, and the other two rooms are dedicated for coronary procedures.

continue reading
Volume 22 - Issue 10 - October, 2014   |   448 reads

Kristin Truesdell, Decision Support Specialist, Corazon, Inc., Pittsburgh, Pennsylvania

Kristin is a Decision Support Specialist with Corazon, Inc., offering a full continuum of services for the heart, vascular, neuro, and orthopedic specialties, with consulting, recruitment, interim management, and software solutions for hospitals n

continue reading
Volume 22 - Issue 10 - October, 2014   |   447 reads

Richard E. Kidd, BSN, RN, CEN, CCRN, RN III Cardiac Catheterization Laboratory and MUSC College of Nursing, Doctor of Nursing Practice, Family Nurse Practitioner candidate, The Medical University of South Carolina, Charleston, South Carolina

Performing RHCs via the antecubital vein is a prudent risk-mitigating and patient comfort strategy, particularly for patients receiving anticoagulant or antiplatelet therapy. This paper examines the purpose of RHCs, reviews the experts’ consensus on performing RHCs on anticoagulated patients, and reports the method currently being used to perform RHC from the antecubital vein.

 

continue reading
Volume 22 - Issue 10 - October, 2014   |   586 reads

Cath Lab Digest talks with Carey Holmquist, Cardiac Manager, and Mike Luedtke, CIS Analyst, St. Patrick Hospital, Missoula, Montana.

We had a huge need to replace our systems, because everything was outdated and separate, including our echo, cath, and registry submission databases. It was very difficult to manage. In order to minimize downtimes, we wanted a virtual server environment. We were actually the first system for McKesson, outside of the beta sites, to go live in a production environment with virtual servers.

continue reading
Volume 22 - Issue 10 - October, 2014   |   391 reads

Control Medical Technology, Park City, Utah, announced the FDA cleared, and the company began shipping, the new Aspire RX-LP6 Rapid-Exchange Mechanical Thrombectomy System to remove fresh blood clots and emboli from coronary and peripheral vasculature.

continue reading
Volume 22 - Issue 10 - October, 2014   |   457 reads

SUPPLEMENTS

MOST VIEWED

9/2/2014   |   249 views   |   0 comments
10/15/2014   |   370 views   |   0 comments